Atom Investors »

Immunovant shares owned by Atom Investors

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Atom Investors from 13F filings

Historical chart of Atom Investors investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Atom Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Atom Investors

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.9M 74k 38.53
2023-12-31 $229k 5.4k 42.13

More positions owned by Atom Investors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Viatris (VTRS)
Intel Corporation (INTC)
Hewlett Packard Enterprise (HPE)
Rhythm Pharmaceuticals (RYTM)
Esab Corporation (ESAB)
Ishares Msci Brazil Etf (EWZ)
Gxo Logistics Incorporated Common Stock (GXO)
Applied Materials (AMAT)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
VSE Corporation (VSEC)
Apple (AAPL)
Immunome (IMNM)
John Bean Technologies Corporation (JBTM)

View all positions for Atom Investors

Top funds holding Immunovant

FMR
Deep Track Capital
BlackRock
Farallon Capital Management
Baker Bros. Advisors
State Street Corporation
TCG Crossover Management
Vanguard Portfolio Management
Morgan Stanley
Vanguard Capital Management
Jennison Associates
Rtw Investments
Two Seas Capital
Armistice Capital
ADAR1 Capital Management

View all funds holding Immunovant